| CXSL1700038 | 重组人血管内皮生长因子受体-抗体融合蛋白注射液 | | Injection | Biological Products(7) | New Drug Application | 2017-06-15 | 齐鲁制药有限公司 | QILU Pharmaceutical Co Ltd | Certificate Issued | 2017-12-21 | view |
| CXSL1700037 | 重组人血管内皮生长因子受体-抗体融合蛋白注射液 | | Injection | Biological Products(7) | New Drug Application | 2017-06-15 | 齐鲁制药有限公司 | QILU Pharmaceutical Co Ltd | Certificate Issued | 2017-12-21 | view |
| CXSL1700036 | 重组人血管内皮生长因子受体-抗体融合蛋白注射液 | | Injection | Biological Products(7) | New Drug Application | 2017-06-15 | 齐鲁制药有限公司 | QILU Pharmaceutical Co Ltd | Certificate Issued | 2017-12-21 | view |
| CXSL2000332 | 重组人血管内皮生长因子受体-抗体融合蛋白眼内注射液 | | Injection | Biological Products(3.3) | New Drug Application | 2020-11-24 | 成都景泽生物制药有限公司 | Chengdu Zeyan Biotechnology Co Ltd | In Review | 2020-11-23 | view |
| CXSL0600044 | 重组人血管内皮生长因子受体-抗体融合蛋白注射液（玻璃体注射） | | Injection | Biological Products(1) | New Drug Application | 2006-08-10 | 成都康弘生物科技有限公司 | Chengdu Kanghong Biotechnology Co Ltd | Certificate Issued | 2007-11-19 | view |
| CYSB0900152 | 重组人血管内皮生长因子受体-抗体融合蛋白注射液(玻璃体注射) | | Injection | Biological Products | Supplementary Application | 2009-06-22 | 成都康弘生物科技有限公司 | Chengdu Kanghong Biotechnology Co Ltd | Certificate Issued | 2010-03-11 | view |
| CXSL1900072 | 重组人血管内皮生长因子受体-抗体融合蛋白注射液 | | Injection | Biological Products(7) | New Drug Application | 2019-07-09 | 山东博安生物技术有限公司 | Shandong BoAn Biotechnology Co Ltd | In Review | 2019-07-08 | view |
| CXSL1900071 | 重组人血管内皮生长因子受体-抗体融合蛋白注射液 | | Injection | Biological Products(7) | New Drug Application | 2019-07-09 | 山东博安生物技术有限公司 | Shandong BoAn Biotechnology Co Ltd | In Review | 2019-07-08 | view |
| CXSL1800132 | 重组人血管内皮生长因子受体-抗体融合蛋白眼用注射液 | | Injection | Biological Products(15) | New Drug Application | 2019-01-04 | 山东博安生物技术有限公司 | Shandong BoAn Biotechnology Co Ltd | In Review | 2019-01-02 | view |
| CXSL2000175 | 重组人血管内皮生长因子受体-抗体融合蛋白眼用注射液 | | Injection | Biological Products(1) | New Drug Application | 2020-07-09 | 华博生物医药技术（上海）有限公司 | Huabo Biopharm Co Ltd | In Review | 2020-07-07 | view |
| CXSL1500123 | 重组人血管内皮生长因子受体-抗体融合蛋白眼用注射液 | | Injection | Biological Products(1) | New Drug Application | 2016-02-25 | 华博生物医药技术（上海）有限公司 | Huabo Biopharm Co Ltd | Certificate Issued | 2017-06-20 | view |
| CXSL2000174 | 重组人血管内皮生长因子受体-抗体融合蛋白眼用注射液 | | Injection | Biological Products(1) | New Drug Application | 2020-07-09 | 华博生物医药技术（上海）有限公司 | Huabo Biopharm Co Ltd | In Review | 2020-07-07 | view |
| CXSL2000173 | 重组人血管内皮生长因子受体-抗体融合蛋白眼用注射液 | | Injection | Biological Products(1) | New Drug Application | 2020-07-09 | 华博生物医药技术（上海）有限公司 | Huabo Biopharm Co Ltd | In Review | 2020-07-07 | view |
| CXSB2400116 | 重组人血管内皮生长因子受体-抗体融合蛋白眼用注射液 | | Injection | Biological Products(1) | Supplementary Application | 2024-10-11 | | Huabo Biopharm Co Ltd | | | view |
| CXSB2101042 | 重组人血管内皮生长因子受体-抗体融合蛋白眼用注射液 | | Injection | Biological Products(1) | Supplementary Application | 2021-09-08 | | Huabo Biopharm Co Ltd | | | view |
| CXSB2101036 | 重组人血管内皮生长因子受体-抗体融合蛋白眼用注射液 | | Injection | Biological Products(1) | Supplementary Application | 2021-08-27 | | Huabo Biopharm Co Ltd | | | view |
